136 related articles for article (PubMed ID: 6531273)
1. Dopamine receptor elevation by cholecystokinin.
Dumbrille-Ross A; Seeman P
Peptides; 1984; 5(6):1207-12. PubMed ID: 6531273
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo.
Rivest R; Jolicoeur FB; Marsden CA
Neuropharmacology; 1991 Jan; 30(1):25-33. PubMed ID: 2046877
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens.
Vickroy TW; Bianchi BR
Neuropeptides; 1989 Jan; 13(1):43-50. PubMed ID: 2466220
[TBL] [Abstract][Full Text] [Related]
4. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
6. Balance of glutamate and dopamine in the nucleus accumbens modulates self-stimulation behavior after injection of cholecystokinin and neurotensin in the rat brain.
Heidbreder C; Gewiss M; De Mot B; Mertens I; De Witte P
Peptides; 1992; 13(3):441-9. PubMed ID: 1523160
[TBL] [Abstract][Full Text] [Related]
7. Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis.
Blaha CD; Coury A; Fibiger HC; Phillips AG
Neuroscience; 1990; 34(3):699-705. PubMed ID: 2352647
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain.
Merchant KM; Bush LG; Gibb JW; Hanson GR
Brain Res; 1989 Oct; 500(1-2):21-9. PubMed ID: 2532557
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic antagonists attenuate neurotensin-stimulated accumbens and striatal dopamine metabolism.
Rivest R; Marsden CA
Neuroscience; 1992; 47(2):341-9. PubMed ID: 1641127
[TBL] [Abstract][Full Text] [Related]
10. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat.
Debonnel G; Gaudreau P; Quirion R; de Montigny C
J Neurosci; 1990 Feb; 10(2):469-78. PubMed ID: 2137531
[TBL] [Abstract][Full Text] [Related]
12. Modulation of [3H]-dopamine binding by cholecystokinin octapeptide (CCK-8).
Murphy RB; Schuster DI
Peptides; 1982; 3(3):539-43. PubMed ID: 6289286
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin interacts with dopaminergic neurons in rat brain.
Reches A; Burke RE; Jiang D; Wagner HR; Fahn S
Peptides; 1983; 4(1):43-8. PubMed ID: 6866808
[TBL] [Abstract][Full Text] [Related]
14. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.
Ladurelle N; Keller G; Blommaert A; Roques BP; Daugé V
Eur J Neurosci; 1997 Sep; 9(9):1804-14. PubMed ID: 9383203
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the stimulatory effect of neurotensin on dopamine release in rat nucleus accumbens slices is independent of dopamine D2-receptor activation.
Reyneke L; Russell VA; Taljaard JJ
Brain Res; 1990 Nov; 534(1-2):188-94. PubMed ID: 1981481
[TBL] [Abstract][Full Text] [Related]
16. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin octapeptide in vitro and ex vivo strongly modulates striatal dopamine D2 receptors in rat forebrain sections.
Li XM; Hedlund PB; Fuxe K
Eur J Neurosci; 1995 May; 7(5):962-71. PubMed ID: 7613631
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
Fuxe K; Agnati LF; Benfenati F; Celani M; Zini I; Zoli M; Mutt V
J Neural Transm Suppl; 1983; 18():165-79. PubMed ID: 6192208
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in rat.
Hétier E; Boireau A; Dubédat P; Blanchard JC
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):13-7. PubMed ID: 3368012
[TBL] [Abstract][Full Text] [Related]
20. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
Prosser ES; Csernansky JG; Hollister LE
Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
